`
`United Therapeutics Announces Promotion oi Robert Roscigno to Vice President. Commercial Development | Evaluate
`
`TM
`
`Evaluate
`
`How We Use Cookies
`
`—s.......
`
`PRODUCTSISSOLUTIONS
`
`NEWS&INSIGHT
`
`RBOU‘TUS
`
`SUPPORT
`
`CONTACTUS
`
`CAREERS
`
`WelcomeZGuastlLoginlkegisler
`
`United Therapeutics Announces Promotion of
`Robert Roscigno to Vice President, Commercial
`Development
`
`Source
`
`Press Release
`
`Company United Therapeutics
`Tags
`Personnel
`Date
`November 06. 2002
`
`Research Triangle Park. NC and Silver Spring. MD -- November 6. 2002 - United Therapeutics Corporation (NASDAQ: UTHR}
`announced today that Robert Roscigno. PhD. has been promoted to Vice President of Commercial Development. in his new
`position. Dr. Roscigno is responsible for worldwide commercial development of Remodulin areg : (treprostinll sodium) injection.
`United Therapeutics’ therapy for the treatment of pulmonary arterial hypertension. Dr. Roscigno previously served as
`Director. Commercial Development.
`
`'1 am extremely pleased to make this promotion.” said Martino Rothblatt. Uniled Therapeuticsflrsquo: Chairman and CEO. "Robert
`was one of the principal scientific developers of Remoduiin . and has also been the key individual responsible for its commercial
`acceptance in the United States and overseas. This promotion is emblematic of our Company‘s emphasis on career growth for our
`most talented professionals.“
`
`Remodulin received United States Food and Drug Administration approval on May 21. 2002. Canadian Therapeutic Products
`Directorate approval on October 4. 2002. and approval from the Israeli Ministry of Health on October 31. 2002. United Therapeutics
`has submitted marketing applications for Remodulin in France . Switzerland and Australia. with additional European filings to
`follow approval in France .
`
`United Therapeutics is a biotechnology company focused on combating cardiovascular. infectious and oncologlcal diseases with
`unique therapeutic products.
`
`Source E\.'Ei||uale""I
`
`9 RED! 0 Bookmarg
`
`@201? Evaluate Ltd. All rights reserved
`
`
`
`http:erwevaiuategroup.comrUniversaWiew.aspx?type=Story&id=33890
`
`1l1
`
`UNITED THERAPEUTICS. EX. 2024
`WATSON LABORATORIES V. UNITED THERAPEUTICS. |PR201T—01621
`Page 1 of1
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
